ArticleFrontiers in nuclear medicine2023

Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer.

Danae Efremia Bajwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.